Taiwan Liposome Company, Ltd. Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities
Taiwan Liposome Company, Ltd. reported Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities of TWD 119.61 million for the 12-month period ending 2020-12-31, per its 20-F filed 2021-03-30.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities · last filed 2021-03-30
| Period end | Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2020-12-31 | 119.61M TWD 20-F · filed 2021-03-30 |
| 2019-12-31 | -94.20M TWD 20-F · filed 2021-03-30 |
| 2018-12-31 | 360.11M TWD 20-F · filed 2021-03-30 |
| 2017-12-31 | -200.00K TWD 20-F · filed 2020-03-10 |